We are live on ! Find out more
YAL

Your Advocates Ltd Portfolio holdings

AUM $350M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.96%
1 Year Est. Return
+21.03%
3 Year Est. Return
+50.04%
5 Year Est. Return
+43.34%
10 Year Est. Return
AUM
$350M
AUM Growth
+$22M
Cap. Flow
-$1.8M
Cap. Flow %
-0.51%
Top 10 Hldgs %
89.84%
Holding
249
New
18
Increased
45
Reduced
37
Closed
39

No holdings matched the selected filter criteria.

Similar funds

Your Advocates Ltd's Q2 2026 Portfolio in Review

As of Q2 2026, Your Advocates Ltd held 249 positions worth $350M, up 6.7% from $328M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Your Advocates Ltd's Q2 2026 filing shows 18 new, 45 increased, 37 reduced and 39 closed positions. Its largest new stake was Rocket Lab Corp: 971 shares worth $98.7K. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $1.56M.

By sector, the portfolio is most concentrated in Energy at 1.4% of assets, down from 1.9% a quarter earlier, followed by Technology and Industrials.

  • Your Advocates Ltd's largest Q2 2026 buy was Rocket Lab Corp: 971 shares worth $98.7K.
  • Your Advocates Ltd added most to Schwab Intermediately-Term US Treasury ETF in Q2 2026, an estimated $1.4M increase.
  • Your Advocates Ltd's biggest Q2 2026 reduction was Dimensional Emerging Markets Core Equity 2 ETF, cutting an estimated $1.56M.
  • Your Advocates Ltd fully exited Monopar Therapeutics in Q2 2026, selling an estimated $183K.
  • Your Advocates Ltd's ten largest holdings make up 90% of its $350M portfolio in Q2 2026.
  • Your Advocates Ltd opened 18 new positions and closed 39 in Q2 2026.
  • Your Advocates Ltd's portfolio value rose 6.7% quarter-over-quarter to $350M.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.